HFA Premium Access

Understanding congestion: thinking beyond diuretic therapy

Event: Heart Failure 2017 - 4th World Congress on Acute Heart Failure
Topic: Acute Heart Failure
Session type: Satellite Symposium
Sponsored by Fresenius Medical Care
Date: 1 May 2017
Time: 12:45 - 13:45

Congress Session

6 presentations in this session

Welcome & introduction.

Speaker: Professor F. Ruschitzka (Zurich, CH)
Speaker: Professor G. Filippatos (Athens, GR)
Thumbnail

Congestion - The key target in the treatment of decompensated heart failure.

Speaker: Professor M. Metra (Brescia, IT)
Thumbnail

The decongestion toolkit: restoring sensitivity to diuretics.

Speaker: Professor P. Ponikowski (Wroclaw, PL)
Thumbnail

Peripheral ultrafiltration: exploring new options for acutely decompensated heart failure.

Speaker: Doctor M. Costanzo (Naperville, US)
Thumbnail

Panel discussion and Q&A.

Speaker: Professor F. Ruschitzka (Zurich, CH)
Speaker: Professor G. Filippatos (Athens, GR)
Thumbnail

Key takeaways (closing).

Speaker: Professor F. Ruschitzka (Zurich, CH)
Thumbnail

8 speakers from this session

Professor Frank Ruschitzka

University Heart Center, Zurich (Switzerland)
82 presentations
2 followers

Professor Gerasimos Filippatos

National & Kapodistrian University of Athens Medical School, Athens (Greece)
55 presentations
1 follower

Professor Marco Metra

University of Brescia, Brescia (Italy)
81 presentations
14 followers

Professor Piotr Ponikowski

Wroclaw Medical University, Wroclaw (Poland)
68 presentations
8 followers

Doctor Maria Rosa Costanzo

Advocate Heart Institute, Naperville (United States of America)
23 presentations
0 follower

Professor Frank Ruschitzka

University Heart Center, Zurich (Switzerland)
82 presentations
2 followers

Professor Gerasimos Filippatos

National & Kapodistrian University of Athens Medical School, Athens (Greece)
55 presentations
1 follower

Professor Frank Ruschitzka

University Heart Center, Zurich (Switzerland)
82 presentations
2 followers

This platform is supported by

logo Novo Nordisk